Comparison of opioid use disorder among male veterans and non‐veterans: Disorder rates, socio‐demographics, co‐morbidities, and quality of life

American Journal on Addictions - Tập 28 Số 2 - Trang 92-100 - 2019
Taeho Greg Rhee1,2, Robert A. Rosenheck3,4,5
1Department of Internal Medicine School of Medicine, Yale University New Haven Connecticut
2Yale Center for Outcomes Research and Evaluation (CORE), Yale-New Haven Hospital, New Haven, Connecticut
3Department of Psychiatry, School of Medicine, Yale University, New Haven, Connecticut
4Veterans Affairs (VA) Connecticut Healthcare System, West Haven, Connecticut
5Veterans Affairs (VA) New England Mental Illness Research, Education and Clinical Centers (MIRECC), West Haven, Connecticut

Tóm tắt

Background and ObjectivesAmidst a surging national crisis of opioid use, concern has been expressed about its impact on veterans, but no study has presented a population‐based comparison of opioid use disorder (OUD) among veterans and non‐veterans. We analyzed national epidemiologic data to compare rates, correlates and impacts of the opioid crisis on male veterans and non‐veterans.MethodsRestricted data from 2012 to 2013 National Epidemiologic Survey on Alcohol and Related Conditions‐III (NESARC‐III) were used to compare veteran and non‐veteran men on rates of OUD, as well as correlates of OUD including socio‐demographic characteristics, psychiatric and substance use co‐morbidities, and reductions in health‐related quality of life (HRQOL).ResultsAbout 2.0% of veterans and 2.7% of non‐veterans, estimated at 418,000 and 2.5 million men, respectively, met criteria for life‐time OUD. In both groups, OUD was associated with younger age, lower income levels, and fewer years of education. OUD was associated minority race among veterans, but with non‐Hispanic white race among non‐veterans. Both veteran and non‐veteran adults with OUD were at least five times more likely than their peers to have both psychiatric and substance use co‐morbidities (p < .001) and they experienced strongly reduced HRQOL scores (Cohen's d = −.50 to −.93).Discussion and ConclusionVeterans and non‐veterans experience similar risk of OUD, similar correlates and adverse HRQOL impacts suggesting that similar treatment approaches may be effective for both groups.Scientific SignificanceOur findings highlight comparable vulnerability of veterans to non‐veterans in both the risk of OUD and adverse effects on HRQOL. (Am J Addict 2018;XX:1–9)

Từ khóa


Tài liệu tham khảo

10.1097/j.pain.0000000000000837

10.15585/mmwr.mm655051e1

Centers for Disease Control and Prevention. Drug Overdose Death Data.2017;https://www.cdc.gov/drugoverdose/data/statedeaths.html. Accessed July 3 2018.

Quinnones S, 2016, Dreamland: The True Tale of America's Opiate Epidemic

Sanger‐KatzM. Bleak New Estimates in Drug Epidemic: A Record 72 000 Overdose Deaths in 2017.The New York Times2018.https://www.nytimes.com/2018/08/15/upshot/opioids‐overdose‐deaths‐rising‐fentanyl.html. Accessed August 15 2018.

GoldbergB. Opioid abuse crisis takes heavy toll on U.S. veterans. 2017;https://www.reuters.com/article/us‐usa‐veterans‐opioids/opioid‐abuse‐crisis‐takes‐heavy‐toll‐on‐u‐s‐veterans‐idUSKBN1DA1B2. Accessed August 31 2018.

10.17226/24781

Center for Ethics and the Role of Law. The Intersection of Opioid Overuse and Veteran Mental Health Challenges.2017;https://www.law.upenn.edu/live/files/6192‐cerl‐report‐on‐ptsd‐and‐opioid‐addiction‐final.

10.1016/j.drugalcdep.2015.12.035

10.1111/ajad.12553

10.1097/j.pain.0000000000000874

10.1081/ADA-120037389

10.1111/j.1532-5415.2005.53020.x

10.1001/archinte.164.4.394

National Institute on Alcohol Abuse and Alcoholism. National Epidemiologic Survey on Alcohol and Related Conditions‐III (NESARC‐III). 2017;https://www.niaaa.nih.gov/research/nesarc‐iii. Accessed August 15 2018.

National Institute on Alcohol Abuse and Alcoholism. National Epidemiologic Survey on Alcohol and Related Conditions‐III (NESARC‐III): Source and accuracy statement. 2018;https://www.niaaa.nih.gov/sites/default/files/NESARC_Final_Report_FINAL_1_8_15.pdf. Accessed August 15 2018.

U.S. Department of Veterans Affairs. National Center for Veterans Analysis and Statistics. 2018;https://www.va.gov/VETDATA/Veteran_Population.asp. Accessed August 16 2018.

10.1001/jamapsychiatry.2015.2132

10.1016/j.drugalcdep.2016.10.038

10.1002/hup.2625

10.1007/s11136-016-1236-3

10.1097/01.mlr.0000135827.18610.0d

10.1097/00005650-199603000-00003

10.1016/S0895-4356(98)00109-7

10.1037/a0015808

Cohen J, 1988, Statistical Power Analysis for the Behavioral Sciences

10.1037/0033-2909.112.1.155

Stata Statistical Software: Release 15 [computer program]. College Station TX: StataCorp LP. 2017.

Substance Abuse Mental Health Services Administration. CBHSQ Data review: Prevalence of past year substance use and mental illness by veteran status in a nationally representative sample. 2016;https://www.samhsa.gov/data/sites/default/files/NSDUH‐DR‐VeteranTrends‐2016/NSDUH‐DR‐VeteranTrends‐2016.pdf. Accessed August 21 2018.

10.1001/jamanetworkopen.2018.0217

10.1001/jama.2015.11859

10.1001/jamapsychiatry.2014.366

10.4088/JCP.15m10386

10.5055/jom.2018.0447

10.1001/jama.289.23.3095

10.1001/archpsyc.62.6.617

10.1097/MLR.0000000000000731

10.1176/appi.ps.201700194

10.1136/bmj.e5205

Mattick RP, 2014, Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence, Cochrane Database Syst Rev, 6, CD002207

Mattick RP, 2009, Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence, Cochrane Database Syst Rev, 8, CD002209

Gowing L, 2017, Buprenorphine for managing opioid withdrawal, Cochrane Database Syst Rev, 2, CD002025

10.1136/bmj.j1550

10.1176/appi.ps.201700363

10.1108/JPMH-08-2016-0033

10.1111/ajad.12188

10.1056/NEJMra1604339

10.1016/j.drugalcdep.2011.10.016

10.1097/HRP.0000000000000075

10.1016/j.drugpo.2010.01.010

Thông tin
Thông tin xuất bản

American Journal on Addictions

Tập 28 Số 2

92-100

Thông tin tác giả